Ceftriaxone and Atacand drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Ceftriaxone (ceftriaxone sodium) and Atacand (candesartan cilexetil). Common drug interactions include dehydration among females and renal failure among males.

The phase IV clinical study analyzes what interactions people have when they take Ceftriaxone and Atacand. It is created by eHealthMe based on reports of 52 people who take the same drugs from the FDA, and is updated regularly.

What is Ceftriaxone?

Ceftriaxone has active ingredients of ceftriaxone sodium. It is often used in typhoid fever. eHealthMe is studying from 40,991 Ceftriaxone users. Check the latest studies of Ceftriaxone.

What is Atacand?

Atacand has active ingredients of candesartan cilexetil. It is often used in high blood pressure. eHealthMe is studying from 22,473 Atacand users. Check the latest studies of Atacand.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 23, 2026

52 people who take Ceftriaxone and Atacand together, and have interactions are studied.

Ceftriaxone and Atacand drug interactions.

What are the common drug interactions of Ceftriaxone and Atacand, by gender? *:

female:

Dehydration (dryness resulting from the removal of water)
Dermatitis bullous (inflammation of the skin characterized by the presence of bullae which are filled with fluid)
Dermatitis exfoliative (widespread scaling of the skin, often with itching (pruritus), skin redness (erythroderma), and hair loss)
Dizziness postural
Drug ineffective
Femur fracture
Hepatic encephalopathy (spectrum of neuropsychiatric abnormalities in patients with liver failure)
Hepatic failure (liver failure)
Hepatitis acute
Hepatotoxicity (chemical-driven liver damage)

male:

Renal failure (kidney dysfunction)
General physical health deterioration (weak health status)
Ascites (accumulation of fluid in the abdominal cavity)
Blood bilirubin increased
Hepatic failure (liver failure)
Multi-organ failure (multisystem organ failure)
Orthostatic hypotension (a medical condition consisting of a sudden decrease in blood pressure when a person stands up)
Anorexia (eating disorder characterized by immoderate food restriction and irrational fear of gaining weight)
Antinuclear factor positive
Autoimmune hepatitis

What are the common drug interactions of Ceftriaxone and Atacand, by age (0-1 to 60+)? *:

0-1:

Orthostatic hypotension (a medical condition consisting of a sudden decrease in blood pressure when a person stands up)

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

Anal abscess
Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)
Fascial infection (infection in muscle surrounding tissue)
Folliculitis (infection of hair root)
Genital abscess (build up of pus in genital)
Groin abscess (pus in groin)
Hyperglycaemia (high blood sugar)
Necrotising fasciitis (an uncommon life-threatening soft-tissue infection)
Obesity (having too much body fat)
Perineal abscess

50-59:

Haematoma (collection of blood outside the blood vessels)
Injury
Abdominal pain
Colitis (inflammation of colon)
Diarrhoea
Hospitalisation
Hyperglycaemia (high blood sugar)
Neoplasm (tumour)
Platelet aggregation nos decreased
Rectal haemorrhage (bleeding from anus)

60+:

Renal failure (kidney dysfunction)
Haematochezia (passage of stools containing blood)
Nausea (feeling of having an urge to vomit)
Small intestinal obstruction (blockage in small intestine)
Spinal cord compression
Streptococcal bacteraemia (a bacterial infection of blood)
Ascites (accumulation of fluid in the abdominal cavity)
Blood bilirubin increased
Hepatic failure (liver failure)
Multi-organ failure (multisystem organ failure)

What are the existing conditions these people have? *

Diabetes: 12 people, 23.08%
Anaemia (lack of blood): 8 people, 15.38%
Type 2 Diabetes: 8 people, 15.38%
High Blood Cholesterol: 7 people, 13.46%
Multiple Myeloma (cancer of the plasma cells): 7 people, 13.46%
Urinary Tract Infection: 6 people, 11.54%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 5 people, 9.62%
Peritonitis Bacterial (inflammation of the peritoneum, the thin tissue that lines the inner wall of the abdomen and covers most of the abdominal organs by bacterial): 5 people, 9.62%
Gastric Disorder (disease of stomach): 5 people, 9.62%
Gout (uric acid crystals building up in the body): 5 people, 9.62%

* Approximation only. Some reports may have incomplete information.

Do you take Ceftriaxone and Atacand?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously